Israeli pharmaceutical giant Teva said Monday that it was buying the generic drug business of Allergan for $40.5 billion, consolidating its position as a world leader in generics.
Teva will pay $33.75 billion in cash and offer $6.75 billion of its stock to Allergan, the company said, in a major move that will further shake up the industry.
Name (required) *
E-mail (required, but will not be published) *
Notify me of follow-up comments
Rudi Garcia faces a daunting first assignment as Marseille coach with the struggling French giants travelling to bitter rivals and reigning champions…
The facade of the world's tallest building, the Burj Khalifa in the Gulf emirate of Dubai, was lit up in pink Thursday…
The London Fashion Week (LFW) is one of the most sought out shows of the year. LFW is an annual fashion event…
Powered and Developed by FilmMatters
Copyright © 2016 Arabtoday